TITLE

FIBRINOLYSIN THERAPY OF THROMBOEMBOLISM: THREE YEARS' EXPERIENCE

AUTHOR(S)
Sheffer, Albert L.; Lisker, Samuel; Nemir Jr., Paul
PUB. DATE
May 1961
SOURCE
Angiology;May1961, Vol. 12 Issue 5, p165
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The clinical evaluation of 67 patients treated with fibrinolysin is presented. Thirty-three cases reported previously are added for follow-up purposes. Thrombophlebitis, pulmonary embolism, vascular surgery and ophthalmologic experience are described. There are a few encouraging examples in each group. Concomitant anticoagulant therapy is administered whenever fibrinolysin is indicated. The low incidence of toxicity with recent infusions is noted. Evaluation of fibrinolysin is dependent upon clinical assessment, since there has not been adequate correlation with in vitro estimation of clot lysis and in vivo thrombolysis. It will still be necessary to treat many more cases before a more definitive impression can be expressed concerning the role of fibrinolysin in thromboembolic therapy.
ACCESSION #
16430956

 

Related Articles

  • THE USE OF FIBRINOLYSIN IN THE PREVENTION OF THROMBUS FORMATION IN SMALL ARTERY ANASTOMOSES. Engler, Harold S.; Christopher, Phillip; Moretz, William H. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p259 

    A study of the use of fibrinolysin in the prevention of thrombus formation in small artery anastomoses is reported. Under the conditions of this experiment no beneficial effect was observed. Our experience with the use of fibrinolysin in 9 vascular operations is also described briefly. With the...

  • FOREWORD. Kakkar, Vijay V. // Drugs;2010 Supplement 2, Vol. 70, p1 

    A foreword to the December 14, 2010 issue of the journal "Drugs" is presented.

  • The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism. Kyrle, Paul Alexander; Eichinger, Sabine // Wiener Klinische Wochenschrift;2003, Vol. 115 Issue 13/14, p471 

    Venous thromboembolism (VTE) is a chronic disease. After withdrawal of oral anticoagulation at least a third of patients will experience a subsequent episode of venous thrombosis. Of these patients, approximately 5% will die from pulmonary embolism. The Austrian Study on Recurrent Venous...

  • THE MANAGEMENT AND MISMANAGEMENT OF ACUTE VENOUS THROMBOSIS (THROMBOPHLEBITIS) OF THE EXTREMITIES. Morris, Leslie E.; Balk, Philip // Angiology;Jun1965, Vol. 16 Issue 6, p339 

    In the treatment of acute venous thrombosis of the extremities, bed rest and antibiotics are not only useless but dangerous. Fibrinolysin is of doubtful value, is very expensive, requires complicated laboratory techniques and carries the hazard of homologous serum hepatitis. Ligation of the...

  • The association of factor V Leiden with various clinical patterns of venous thromboembolism—the factor V Leiden paradox. Hirmerova, J.; Seidlerova, J.; Subrt, I. // QJM: An International Journal of Medicine;Sep2014, Vol. 107 Issue 9, p715 

    Background: Factor V Leiden (FVL) supposedly carries relatively higher risk of deep vein thrombosis (DVT), compared to the risk of pulmonary embolism (PE).Aim: To prove this paradox in a group of patients with various clinical presentation of venous thromboembolism (VTE).Materials and methods:...

  • Spontaneous superficial venous thrombophlebitis: Does it increase risk for thromboembolism? van Weert, H.; Dolan, G.; Wichers, I.; de Vries, C.; ter Riet, G.; Buller, H. // Journal of Family Practice;Jan2006, Vol. 55 Issue 1, p52 

    Objectives To determine the risk of arterial and venous complications after a spontaneous superficial venous thrombophlebitis (SVTP) in the leg in a general practice population. Study design Retrospective cohort study (LOE: 2b [CEBM]). Exposure consisted of the diagnosis of SVTP of the lower...

  • Upper extremity deep vein thrombosis. Bontas, Ecaterina; Timofte, Delia; Caparros, Mario Parreno; Ionescu, Dorin; Bartos, Daniela; Olteanu, Dan; Dorobantu, Maria // Maedica - a Journal of Clinical Medicine;2007, Vol. 2 Issue 2, p123 

    Upper extremity deep vein thrombosis (UEDVT) refers to thrombosis of the axillary and/or of the subclavian veins of the thoracic aperture. Based on pathogenesis UEDVT is classified as primary and secondary. Primary UEDVT is a rare disorder represented by Paget-Schroetter syndrome (or...

  • Thromboembolic disorders. Rodman, Morton J. // RN;Jun76, Vol. 39 Issue 6, p79 

    Part I. Presents information on acute thrombophlebitis and pulmonary embolism. Drug used in treating thrombophlebitis and pulmonary embolism; Types of periodic tests for the clotting time of the patient's blood; Information on the anti-inflammatory drug phenylbutazone or Butazolidin.

  • THE TREATMENT OF PULMONARY EMBOLISM WITH FIBRINOLYSIN. Sheffer, Albert L.; Israel, Harold L. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p292 

    An attempt has been made to evaluate fibrinolysin in 33 patients treated for pulmonary embolism or related thrombolic diseases. Six cases of pulmonary embolism are presented in detail. The results suggest that fibrinolysin by itself may not be effective in preventing recurrent embolism. However,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics